Leveraging COVID-19 vaccination to promote hepatitis C screening.

Autor: Vanderhoff A; Viral Hepatitis Care Network , Toronto , Ontario , Canada.; Toronto Centre for Liver Disease , University Health Network, University of Toronto , Toronto , Ontario , Canada., Smookler D; Viral Hepatitis Care Network , Toronto , Ontario , Canada.; Toronto Centre for Liver Disease , University Health Network, University of Toronto , Toronto , Ontario , Canada., Biondi MJ; Viral Hepatitis Care Network , Toronto , Ontario , Canada.; Toronto Centre for Liver Disease , University Health Network, University of Toronto , Toronto , Ontario , Canada., Enman S; Addiction Medical Services , Toronto , Ontario , Canada., Fuliang T; Viral Hepatitis Care Network , Toronto , Ontario , Canada., Mahmood S; Viral Hepatitis Care Network , Toronto , Ontario , Canada., Crespi A; Viral Hepatitis Care Network , Toronto , Ontario , Canada., Marquez M; Viral Hepatitis Care Network , Toronto , Ontario , Canada.; Toronto Centre for Liver Disease , University Health Network, University of Toronto , Toronto , Ontario , Canada., Van Uum R; Viral Hepatitis Care Network , Toronto , Ontario , Canada., You L; Viral Hepatitis Care Network , Toronto , Ontario , Canada., Wolfson-Stofko B; Viral Hepatitis Care Network , Toronto , Ontario , Canada.; Toronto Centre for Liver Disease , University Health Network, University of Toronto , Toronto , Ontario , Canada., Logan R; Centre for Addiction and Mental Health , Toronto , Ontario , Canada., LeDrew E; Centre for Addiction and Mental Health , Toronto , Ontario , Canada., Shah H; Viral Hepatitis Care Network , Toronto , Ontario , Canada.; Toronto Centre for Liver Disease , University Health Network, University of Toronto , Toronto , Ontario , Canada., Janssen H; Viral Hepatitis Care Network , Toronto , Ontario , Canada.; Toronto Centre for Liver Disease , University Health Network, University of Toronto , Toronto , Ontario , Canada., Capraru C; Viral Hepatitis Care Network , Toronto , Ontario , Canada.; Toronto Centre for Liver Disease , University Health Network, University of Toronto , Toronto , Ontario , Canada., Venier E; Addiction Medical Services , Toronto , Ontario , Canada., Feld JJ; Viral Hepatitis Care Network , Toronto , Ontario , Canada.; Toronto Centre for Liver Disease , University Health Network, University of Toronto , Toronto , Ontario , Canada.
Jazyk: angličtina
Zdroj: Hepatology communications [Hepatol Commun] 2022 Nov 03; Vol. 7 (1), pp. e2101. Date of Electronic Publication: 2022 Nov 03 (Print Publication: 2023).
DOI: 10.1002/hep4.2101
Abstrakt: Health care initiatives, such as hepatitis C virus (HCV) screening, have been greatly overshadowed by the corona virus disease 2019 (COVID-19) pandemic. However, COVID-19 vaccination programs also provide an opportunity to engage with a high volume of people in a health care setting. We collaborated with a large COVID vaccination center to offer HCV point-of-care testing followed by dried blood spot collection for HCV RNA. Additionally, this opportunity was used to evaluate the practical significance of a 5-minute version of the OraQuick HCV antibody test in lieu of the standard 20-minute test. We tested 2317 individuals; 31 were HCV antibody positive and six were RNA positive of which four were treated and reached sustained virological response. Over a third of those surveyed said they would not have participated had the test required 20 minutes. Conclusion : Colocalizing HCV testing and linkage to care at a COVID vaccination clinic was found to be highly feasible; furthermore, a shortened antibody test greatly improves the acceptance of testing.
(Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc on behalf of the American Association for the Study of Liver Diseases.)
Databáze: MEDLINE
Externí odkaz: